Vera Therapeutics Statistics
Total Valuation
VERA has a market cap or net worth of $1.87 billion. The enterprise value is $1.56 billion.
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VERA has 72.30 million shares outstanding. The number of shares has increased by 11.54% in one year.
| Current Share Class | 72.30M |
| Shares Outstanding | 72.30M |
| Shares Change (YoY) | +11.54% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 96.33% |
| Float | 49.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 179.39 |
| Forward PS | 9.31 |
| PB Ratio | 5.68 |
| P/TBV Ratio | 5.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 149.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.91, with a Debt / Equity ratio of 0.23.
| Current Ratio | 7.91 |
| Quick Ratio | 7.15 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -57.40 |
Financial Efficiency
Return on equity (ROE) is -113.46% and return on invested capital (ROIC) is -60.31%.
| Return on Equity (ROE) | -113.46% |
| Return on Assets (ROA) | -54.35% |
| Return on Invested Capital (ROIC) | -60.31% |
| Return on Capital Employed (ROCE) | -104.28% |
| Weighted Average Cost of Capital (WACC) | 10.65% |
| Revenue Per Employee | $28,390 |
| Profits Per Employee | -$1.15M |
| Employee Count | 362 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VERA has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.42% in the last 52 weeks. The beta is 1.19, so VERA's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -12.42% |
| 50-Day Moving Average | 30.59 |
| 200-Day Moving Average | 35.87 |
| Relative Strength Index (RSI) | 34.43 |
| Average Volume (20 Days) | 1,436,126 |
Short Selling Information
The latest short interest is 12.14 million, so 16.79% of the outstanding shares have been sold short.
| Short Interest | 12.14M |
| Short Previous Month | 13.59M |
| Short % of Shares Out | 16.79% |
| Short % of Float | 24.63% |
| Short Ratio (days to cover) | 7.14 |
Income Statement
In the last 12 months, VERA had revenue of $10.28 million and -$415.31 million in losses. Loss per share was -$5.91.
| Revenue | 10.28M |
| Gross Profit | 6.98M |
| Operating Income | -427.53M |
| Pretax Income | -415.31M |
| Net Income | -415.31M |
| EBITDA | -426.30M |
| EBIT | -427.53M |
| Loss Per Share | -$5.91 |
Full Income Statement Balance Sheet
The company has $384.04 million in cash and $76.79 million in debt, with a net cash position of $307.25 million or $4.25 per share.
| Cash & Cash Equivalents | 384.04M |
| Total Debt | 76.79M |
| Net Cash | 307.25M |
| Net Cash Per Share | $4.25 |
| Equity (Book Value) | 333.19M |
| Book Value Per Share | 4.61 |
| Working Capital | 385.51M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$375.92 million and capital expenditures -$125,000, giving a free cash flow of -$376.05 million.
| Operating Cash Flow | -375.92M |
| Capital Expenditures | -125,000 |
| Depreciation & Amortization | 1.23M |
| Net Borrowing | n/a |
| Free Cash Flow | -376.05M |
| FCF Per Share | -$5.20 |
Full Cash Flow Statement Margins
| Gross Margin | 67.93% |
| Operating Margin | -4,160.07% |
| Pretax Margin | -4,041.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VERA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.54% |
| Shareholder Yield | -11.54% |
| Earnings Yield | -22.91% |
| FCF Yield | -20.40% |
Analyst Forecast
The average price target for VERA is $71.36, which is 176.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $71.36 |
| Price Target Difference | 176.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VERA has an Altman Z-Score of 6.7 and a Piotroski F-Score of 1.
| Altman Z-Score | 6.7 |
| Piotroski F-Score | 1 |